Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation
Frontiers in Cardiovascular Medicine · 15.05.2026 · 13
DOI: 10.3389/fcvm.2026.1656903 ↗Kurz gefasst
Fachartikel in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 15.05.2026. Verfasst von Yuhang Wei und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Key Laboratory of Cardiac Injury and Repair of Henan Province, First Affiliated Hospital of Zhengzhou University, Zhengzhou…. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Atrial fibrillation (AF) recurrence remains a major limitation after radiofrequency catheter ablation (RFCA), especially in patients with hypertension. Systemic immune-inflammation index (SII) has emerged as a novel marker of systemic inflammation, yet its prognostic value in this population is unclear.
Objective
To assess the predictive value of pre-ablation SII for AF recurrence and explore the modifying effect of blood pressure (BP) control status in hypertensive patients.
Methods
In this retrospective cohort study, 568 hypertensive AF patients undergoing first-time RFCA were enrolled. Patients were stratified by SII quartiles and BP control status. Cox regression, ROC analysis, and restricted cubic spline modeling were used to evaluate associations with AF recurrence.
Results
During a mean 34-month follow-up, 17.3% experienced AF recurrence. Elevated SII was independently associated with recurrence risk (HR per 100-unit increase: 1.138; P < 0.001). Patients with both high SII and poorly controlled BP had a > 4-fold increased risk (HR: 4.061). SII outperformed conventional markers and significantly improved model discrimination (C-statistic: 0.755).
Conclusion
Pre-ablation SII is an independent and superior predictor of AF recurrence after RFCA in hypertensive patients, particularly when BP is poorly controlled. Combined assessment of SII and BP control may improve individualized risk stratification.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Key Laboratory of Cardiac Injury and Repair of Henan Province, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
- Department of Cardiology, Beijing Anzhen Hospital of Capital Medical University and Beijing Institute of Heart Lung and Blood Vessel Diseases, Beijing, China.
Zitieren
APA
Wei, Y., Cao, C., Wang, Y., Yang, P., Zhang, W., Shangguan, J., Wang, X., Gao, J., Zong, W., & Liu, G. (2026). Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation. Frontiers in Cardiovascular Medicine, 13. https://doi.org/10.3389/fcvm.2026.1656903
Vancouver
Wei Y, Cao C, Wang Y, Yang P, Zhang W, Shangguan J, et al. Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation. Frontiers in Cardiovascular Medicine. 2026;13. doi:10.3389/fcvm.2026.1656903
BibTeX
@article{Wei2026,
author = {Wei, Yuhang and Cao, Chenxi and Wang, Yunzhe and Yang, Pengli and Zhang, Wenjing and Shangguan, Jiahong and Wang, Xijia and Gao, Jiaqi and Zong, Wenzhe and Liu, Gangqiong},
title = {Systemic immune-inflammation Index and blood pressure control are independent and interactive predictors of atrial fibrillation recurrence after ablation},
journal = {Frontiers in Cardiovascular Medicine},
year = {2026},
volume = {13},
doi = {10.3389/fcvm.2026.1656903}
}
EUVIMED